SCHEMBL18409498

SCHEMBL18409498

N#Cc1ccc(N2CCN(Cc3nc(-c4ccccc4)c(-c4cccc(-c5cccc(-c6nc(CN7CCN(C(=O)c8ccccc8)CC7)[nH]c6-c6ccccc6)c5)c4)[nH]3)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 1/20 0.49
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KCNA5 P22460 1/20 0.43
FASN P49327 3/20 0.43
NAMPT P43490 3/20 0.42
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
POLB P06746 1/20 0.41
SLC6A7 Q99884 2/20 0.41
DRD2 P14416 3/20 0.41
HTR2A P28223 1/20 0.41
CYP11B2 P19099 2/20 0.41
CYP11B1 P15538 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409506 0.91 CYP3A4 (0.45) SMOALDH1A1KDM4EMEN1HPGD
SCHEMBL18409483 0.85 DRD4 (0.50) ALDH1A1POLBDRD2DRD4DRD3
SCHEMBL18409495 0.82 KDM4E (0.52) SMOALDH1A1KDM4EMEN1MAPT
SCHEMBL18409488 0.80 DRD4 (0.48) ALDH1A1KDM4EDRD2HTR2ACYP11B2
SCHEMBL18409476 0.79 ALDH1A1 (0.49) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL20419759 0.76 ATM (0.49) ALDH1A1MEN1KMT2A
SCHEMBL18409487 0.75 DRD4 (0.60) ALDH1A1MAPTDRD2DRD4DRD3
SCHEMBL18409478 0.74 ALDH1A1 (0.53) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL20347007 0.74 LMNA (0.67) ALDH1A1MEN1MAPTKMT2AKCNA5
SCHEMBL18409479 0.74 ALDH1A1 (0.47) ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017011920-A1 COMPOUNDS AND USES THEREOF IN THE TREATMENT OF CANCERS AND OTHER MEDICAL CONDITIONS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-01-26 WO disclosed